Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha

FEMS Microbiology Letters

Volumn 328, Issue 1, 2012, Pages 13-19

  Hee Kim, Chung ^a   Geun Kim, Han ^b   Yun Kim, Joo ^a   Ra Kim, Na ^a   Jun Jung, Bong ^a   Hye Jeong, Ji ^a   Kyun Chung, Dae ^a  

^a Kyung Hee University   (South Korea)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genomic DNA; Inflammation; Probiotics; THP 1 cells; Tumor necrosis factor alpha

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GENOMIC DNA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA PURIFICATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LACTOBACILLUS PLANTARUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL LINE; DNA; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LACTOBACILLUS PLANTARUM; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MONOCYTES; NF-KAPPA B; PROBIOTICS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

LACTOBACILLUS PLANTARUM;

EID: 84856471091     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2011.02470.x     Document Type: Article

References (22)

1. Bates DW, Pruess KE & Lee TH (1995) How bad are bacteremia and sepsis: outcomes in a cohort with suspected bacteremia. Arch Intern Med 155: 593-598.
2. Bengmark S (2000) Pre-, pro-, and synbiotics. Curr Opin Clin Nutr Metab Care 4: 571-579.
3. Cook DN, Pisetsky DS & Schwartz DA (2004) Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5: 975-979.
4. Dalpke A, Frank J, Peter M & Heeg K (2006) Activation of toll like receptor 9 by DNA from different bacterial species. Infect Immun 74: 940-946.
5. DeFranco AL, Crowley MT, Finn A, Hambleton J & Weinstein SL (1998) The role of tyrosine kinases and map kinases in LPS-induced signaling.Prog. Clin Biol Res 397: 119-136.
6. Geerdes HF, Ziegler D, Lode H, Hund M, Loehr A, Fangmann W & Wagner J (1992) Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 15: 991-1002.
7. Glauser MP, Zanetti G, Baumgaryner JD & Cohen J (1991) Septic: pathogenesis. Lancet 338: 732-736.
8. Hemmi H, Takeuchi O, Kawai T et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
9. Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73: 1142S-1146S.
10. Jacinto R, Hartung T, McCall C & Li L (2002) Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol 168: 6136-6141.
11. Kim HG, Kim NR, Gim MG, Lee JM, Lee SY, Ko MH, Kim JY, Han SH & Chung DK (2008) Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-α production in THP-1 cells and endotoxin shock in mice. J Immunol 180: 2553-2561.
12. Kumagai Y, Takeuchi O & Akira S (2008) TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 60: 795-804.
13. Lakhani SA & Bogue CW (2003) Toll-like receptor signaling in sepsis. Curr Opin Pediatr 15: 278-282.
14. Lehner MD, Morath S, Michelsen KS, Schumann RR & Hartung T (2001) Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 166: 5161-5167.
15. Medvedev AE, Kopydlowdki KM & Vogel SN (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J Immunol 164: 5564-5574.
16. Miggin SM & O'Neill LA (2006) New insights into the regaulation of TLR signaling. J Leukoc Biol 80: 220-226.
17. Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ & Sturgill TW (1991) Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10: 885-892.
18. Sugawara S, Arakaki R, Rikiishi H & Takada H (1999) Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner. Infect Immun 67: 1623-1632.
19. Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M & Klinmam DM (2001) Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167: 3555-3558.
20. Ulevitch RJ & Tobias PS (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13: 437-457.
21. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A & Beyaert R (2008) TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 65: 2964-2978.
22. Yang S, Tamai R, Akashi S, Takeuchi O, Akira S, Sugawara S & Takada H (2001) Synergistic effect of muramyl dipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 69: 2045-2053.